Mao Jianhua
Mao Jianhua
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence | Nephrotic Syndrome in Children | Recruiting | Phase 2 | 2026-02-27 | NCT07087314 | |
| Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome | FRNS/SDNS; Ripertamab | Not yet recruiting | Not applicable | 2026-02-05 | NCT07388810 | |
| Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 | 2025-11-28 | NCT06789107 | |
| Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial. | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Phase 3 | 2023-10-12 | NCT06079788 |